Post-infectious irritable bowel syndrome following a diagnosis of traveller's diarrhoea : a comprehensive characterization of clinical and laboratory parameters

© International Society of Travel Medicine 2023. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissionsoup.com..

BACKGROUND: Prolonged or recurrent gastrointestinal symptoms may persist after acute traveller's diarrhoea (TD), even after adequate treatment of the primary cause. This study aims to describe the epidemiological, clinical and microbiological characteristics of patients with post-infectious irritable bowel syndrome (PI-IBS) after returning from tropical or subtropical areas.

METHODS: We conducted a retrospective study of patients presenting between 2009 and 2018 at the International Health referral centre in Barcelona with persistent gastrointestinal symptoms following a diagnosis of TD. PI-IBS was defined as the presence of persistent or recurrent gastrointestinal manifestations for at least 6 months after the diagnosis of TD, a negative stool culture for bacterial pathogens and a negative ova and parasite exam after targeted treatment. Epidemiological, clinical and microbiological variables were collected.

RESULTS: We identified 669 travellers with a diagnosis of TD. Sixty-eight (10.2%) of these travellers, mean age 33 years and 36 (52.9%) women, developed PI-IBS. The most frequently visited geographical areas were Latin America (29.4%) and the Middle East (17.6%), with a median trip duration of 30 days (IQR 14-96). A microbiological diagnosis of TD was made in 32 of these 68 (47%) patients, 24 (75%) of whom had a parasitic infection, Giardia duodenalis being the most commonly detected parasite (n = 20, 83.3%). The symptoms persisted for a mean of 15 months after diagnosis and treatment of TD. The multivariate analysis revealed that parasitic infections were independent risk factors for PI-IBS (OR 3.0, 95%CI 1.2-7.8). Pre-travel counselling reduced the risk of PI-IBS (OR 0.4, 95%CI 0.2-0.9).

CONCLUSIONS: In our cohort, almost 10% of patients with travellers' diarrhoea developed persistent symptoms compatible with PI-IBS. Parasitic infections, mainly giardiasis, seem to be associated with PI-IBS.

Errataetall:

ErratumIn: J Travel Med. 2023 Mar 29;:. - PMID 36999683

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:30

Enthalten in:

Journal of travel medicine - 30(2023), 6 vom: 31. Okt.

Sprache:

Englisch

Beteiligte Personen:

España-Cueto, Sergio [VerfasserIn]
Oliveira-Souto, Inés [VerfasserIn]
Salvador, Fernando [VerfasserIn]
Goterris, Lidia [VerfasserIn]
Treviño, Begoña [VerfasserIn]
Sánchez-Montalvá, Adrián [VerfasserIn]
Serre-Delcor, Núria [VerfasserIn]
Sulleiro, Elena [VerfasserIn]
Rodríguez, Virginia [VerfasserIn]
Aznar, Maria Luisa [VerfasserIn]
Bosch-Nicolau, Pau [VerfasserIn]
Espinosa-Pereiro, Juan [VerfasserIn]
Pou, Diana [VerfasserIn]
Molina, Israel [VerfasserIn]

Links:

Volltext

Themen:

Entamoeba
Giardia duodenalis
Intestinal parasites
Journal Article
Research Support, Non-U.S. Gov't
Shigella

Anmerkungen:

Date Completed 08.11.2023

Date Revised 15.11.2023

published: Print

ErratumIn: J Travel Med. 2023 Mar 29;:. - PMID 36999683

Citation Status MEDLINE

doi:

10.1093/jtm/taad030

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM353874450